Detalles de la búsqueda
1.
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
Br J Cancer
; 130(3): 434-441, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38102226
2.
Association of prior local therapy and outcomes with programmed-death ligand-1 inhibitors in advanced urothelial cancer.
BJU Int
; 130(5): 592-603, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34597472
3.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(7): 931-945, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34051178
4.
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.
Cancer Immunol Immunother
; 70(12): 3679-3692, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351436
5.
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.
Radiology
; 299(1): 109-119, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33497314
6.
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes.
BJU Int
; 128(2): 196-205, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33556233
7.
Metastatic nonclear renal cell carcinoma current review in evolving treatment strategies.
Curr Opin Urol
; 31(3): 242-248, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33742977
8.
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
Cancer
; 126(6): 1208-1216, 2020 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31829450
9.
Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.
J Urol
; 204(1): 63-70, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31971495
10.
Targeting DNA Repair Defects for Precision Medicine in Prostate Cancer.
Curr Oncol Rep
; 21(5): 42, 2019 03 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919167
11.
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.
Lancet Oncol
; 18(5): 672-681a, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389316
12.
Role of immunotherapy in castration-resistant prostate cancer (CRPC).
BJU Int
; 113(3): 367-75, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23650874
13.
Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment.
Clin Transl Oncol
; 25(12): 3556-3564, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37217634
14.
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
Cancers (Basel)
; 15(11)2023 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37296940
15.
Atezolizumab plus Magrolimab, Niraparib, or Tocilizumab versus Atezolizumab Monotherapy in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Multicenter, Randomized Umbrella Study (MORPHEUS Urothelial Carcinoma).
Clin Cancer Res
; 29(21): 4373-4384, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37651261
16.
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM Study.
Eur Urol Oncol
; 2023 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37838555
17.
Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease.
Front Oncol
; 12: 970199, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36267983
18.
SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021).
Clin Transl Oncol
; 24(4): 613-624, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347572
19.
Radium-223 for patients with metastatic castration-resistant prostate cancer with asymptomatic bone metastases progressing on first-line abiraterone acetate or enzalutamide: A single-arm phase II trial.
Eur J Cancer
; 173: 317-326, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35981452
20.
Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice.
Front Med (Lausanne)
; 9: 891179, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36072949